← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2004Last known activity
Dec 1, 2011
Acquired by Actavis → Allergan PLC (2015) → AbbVie on Mar 18, 2005
Timeline
Drugs by trial phase (10 distinct, 9 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (9)
- NCT01228383Overall official - principal investigatorPhase 2Dec 1, 2011
- NCT01501799Study directorN/AJul 1, 2011
- NCT01378312Overall official - principal investigatorPhase 1Feb 1, 2011
- NCT01166087Overall official - principal investigatorPhase 1Feb 1, 2006
- NCT01166100Overall official - principal investigatorPhase 1Feb 1, 2006
- NCT01131780Overall official - principal investigatorPhase 1Oct 1, 2004
- NCT01132222Overall official - principal investigatorPhase 1Sep 1, 2004
- NCT01131728Overall official - principal investigatorPhase 1Jul 1, 2004
- NCT01131767Overall official - principal investigatorPhase 1Jul 1, 2004
Details
- Founded
- Bangalore, IN Jun 1, 2001
- Last known activity
- Dec 1, 2011